Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment of hyperlipidaemia.

D R Illingworth1

  • 1Department of Medicine, Oregon Health Sciences University, Portland.

British Medical Bulletin
|October 1, 1990
PubMed
Summary

This review discusses managing hyperlipidaemia, focusing on reducing atherogenic lipoproteins through diet and medication. It covers hypercholesterolaemia, combined hyperlipidaemia, and severe hypertriglyceridaemia treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type IIa hypercholesterolemia.

Digestive diseases and sciences·2005
Same author

Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus.

The American journal of cardiology·2001
Same author

A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.

Current medical research and opinion·2001
Same author

HMG-CoA reductase inhibitors.

Advances in protein chemistry·2001
Same author

Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function.

Metabolism: clinical and experimental·2001
Same author

Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia.

Journal of lipid research·2000

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Pharmacology

Background:

  • Hyperlipidaemia management aims to lower atherogenic lipoproteins and prevent lipid deposition in arteries.
  • Severe hypertriglyceridaemia requires specific management to prevent complications like hyperchylomicronaemia.
  • Identifying and treating secondary causes of hyperlipidaemia is crucial.

Purpose of the Study:

  • To review the therapeutic strategies for managing hyperlipidaemia, including diet and drug interventions.
  • To outline the treatment approaches for specific hyperlipidaemia subtypes: hypercholesterolaemia, combined hyperlipidaemia, and severe hypertriglyceridaemia.

Main Methods:

  • Dietary modification as the primary therapeutic approach.
  • Individualized drug therapy initiated after diet failure.
  • Review of treatment for elevated low-density lipoproteins (LDL), very-low-density lipoproteins (VLDL), and chylomicrons.

Main Results:

  • Diet is fundamental in managing hyperlipidaemia.
  • Pharmacological intervention is considered when diet alone is insufficient.
  • Tailored treatment plans are necessary for different lipid profiles.

Conclusions:

  • Effective hyperlipidaemia management involves lifestyle changes and, when necessary, pharmacotherapy.
  • Understanding lipid profiles guides treatment decisions for cardiovascular risk reduction.
  • Comprehensive management addresses both primary and secondary lipid disorders.

Related Experiment Videos